Differences in immunoreactivity of estrogen receptor (ER) in tamoxifen-sensitive and -resistant breast carcinomas: preclinical and first clinical investigations.
about
Differences in immunoreactivity of estrogen receptor (ER) in tamoxifen-sensitive and -resistant breast carcinomas: preclinical and first clinical investigations.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Differences in immunoreactivit ...... first clinical investigations.
@en
Differences in immunoreactivity of estrogen receptor
@nl
type
label
Differences in immunoreactivit ...... first clinical investigations.
@en
Differences in immunoreactivity of estrogen receptor
@nl
prefLabel
Differences in immunoreactivit ...... first clinical investigations.
@en
Differences in immunoreactivity of estrogen receptor
@nl
P2093
P2860
P356
P1476
Differences in immunoreactivit ...... first clinical investigations.
@en
P2093
P2860
P2888
P356
10.1023/A:1006334131241
P407
P577
2000-03-01T00:00:00Z
P6179
1006869506